VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMRXAmneal Pharmaceuticals, Inc.
$17.15$5.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMRXQuarterly Financials

Amneal Pharmaceuticals, Inc. (AMRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Amneal Pharmaceuticals, Inc. (AMRX) quarterly income statement — complete revenue, gross profit & net income history

AMRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue722.52M814.32M784.51M724.51M695.42M730.52M702.47M701.78M659.19M616.98M620.04M599.05M557.54M609.76M545.56M559.36M497.63M536.9M528.59M535.08M
Revenue Growth %3.9%11.47%11.68%3.24%5.5%18.4%13.29%17.15%18.23%1.18%13.65%7.1%12.04%13.57%3.21%4.54%0.92%5.27%1.79%15.15%
Cost of Goods Sold402.41M517.13M510.54M438.25M439.53M467.64M432.91M451.83M421.13M391.5M387.51M379.02M379.35M394.37M351.33M358.84M323.06M370.49M330.08M322.58M
COGS % of Revenue55.69%63.5%65.08%60.49%63.2%64.02%61.63%64.38%63.89%63.45%62.5%63.27%68.04%64.68%64.4%64.15%64.92%69.01%62.45%60.29%
Gross Profit320.11M297.19M273.97M286.25M255.89M262.87M269.56M249.95M238.06M225.48M232.53M220.02M178.19M215.39M194.23M200.52M174.57M166.4M198.51M212.5M
Gross Margin %44.31%36.5%34.92%39.51%36.8%35.98%38.37%35.62%36.11%36.55%37.5%36.73%31.96%35.32%35.6%35.85%35.08%30.99%37.55%39.71%
Gross Profit Growth %25.1%13.05%1.64%14.53%7.49%16.58%15.92%13.6%33.6%4.69%19.72%9.73%2.07%29.44%-2.16%-5.64%-8.87%-0.4%48.6%47.33%
Operating Expenses186.58M182.69M274.09M174.88M155.54M187.08M180.75M154.48M248.81M211.29M156.88M139.94M143.74M179.36M149.88M399.14M151.27M155.23M170M145.38M
OpEx % of Revenue25.82%22.43%34.94%24.14%22.37%25.61%25.73%22.01%37.74%34.25%25.3%23.36%25.78%29.41%27.47%71.36%30.4%28.91%32.16%27.17%
Selling, General & Admin186.58M146.46M137.81M124.27M118.29M128.69M118.69M116.46M112.59M109M113.01M105.57M102.1M102.16M100.07M98.81M98.67M97.22M91.4M86.16M
SG&A % of Revenue25.82%17.99%17.57%17.15%17.01%17.62%16.9%16.6%17.08%17.67%18.23%17.62%18.31%16.75%18.34%17.66%19.83%18.11%17.29%16.1%
Research & Development38.38M34.82M63.35M49.98M41.81M56.12M61.1M37.1M39.3M46.56M42.26M38.62M40.33M43.27M51.65M51.57M53.56M53.02M50.55M54.23M
R&D % of Revenue5.31%4.28%8.08%6.9%6.01%7.68%8.7%5.29%5.96%7.55%6.82%6.45%7.23%7.1%9.47%9.22%10.76%9.87%9.56%10.13%
Other Operating Expenses-1000K1000K1000K634K-1000K1000K960K919K1000K1000K1000K-1000K1000K1000K-1000K1000K-961K1000K1000K1000K
Operating Income133.54M114.5M-117K111.37M100.35M75.79M88.81M95.47M-10.75M14.19M75.65M80.08M34.45M36.03M44.35M-198.62M23.3M11.18M28.52M67.12M
Operating Margin %18.48%14.06%-0.01%15.37%14.43%10.38%12.64%13.6%-1.63%2.3%12.2%13.37%6.18%5.91%8.13%-35.51%4.68%2.08%5.39%12.54%
Operating Income Growth %33.08%51.07%-100.13%16.66%1033.81%434.02%17.4%19.21%-131.19%-60.61%70.56%140.32%47.82%222.43%55.54%-395.92%-49.23%-44.62%1071.05%524.3%
EBITDA176.73M163.73M53.96M171.49M160.51M141.92M147.77M151.04M44.78M71.13M132.85M137.19M92.6M97.09M105.96M-138.92M81.12M72.36M88.7M123.61M
EBITDA Margin %24.46%20.11%6.88%23.67%23.08%19.43%21.04%21.52%6.79%11.53%21.43%22.9%16.61%15.92%19.42%-24.84%16.3%13.48%16.78%23.1%
EBITDA Growth %10.11%15.36%-63.49%13.53%258.42%99.54%11.23%10.09%-51.64%-26.74%25.38%198.76%14.15%34.18%19.46%-212.39%-20.04%-9.61%43.54%79.6%
D&A (Non-Cash Add-back)43.19M49.23M54.07M60.11M60.16M66.13M58.96M55.57M55.53M56.93M57.21M57.11M58.15M61.06M61.61M59.7M57.81M61.18M60.19M56.49M
EBIT133.54M111.47M57.59M116.81M94.42M46.34M80.93M86.12M-9.82M-23.91M73.87M80.52M39.89M39.37M44.57M-197.11M23.41M17.64M32.36M68.91M
Net Interest Income-53.36M-56.24M-62.81M-65.1M-56.94M-61.66M-65.51M-65.72M-65.7M-59.55M-50.91M-50.86M-49.31M-47.03M-42.39M-35.62M-33.34M-33.96M-34.4M-34.08M
Interest Income00000000000000000000
Interest Expense53.36M56.24M62.81M65.1M56.94M61.66M65.51M65.72M65.7M59.55M50.91M50.86M49.31M47.03M42.39M35.62M33.34M33.96M34.4M34.08M
Other Income/Expense-53.36M-59.27M-5.11M-59.66M-62.86M-91.11M-73.39M-75.06M-64.78M-97.65M-52.69M-50.42M-43.88M-43.69M-42.17M-34.11M-33.23M-27.49M-30.56M-32.3M
Pretax Income80.18M55.23M-5.22M51.71M37.49M-15.32M15.42M20.41M-75.52M-83.46M22.96M29.66M-9.43M-7.66M2.18M-232.73M-9.92M-16.32M-2.04M34.82M
Pretax Margin %11.1%6.78%-0.67%7.14%5.39%-2.1%2.2%2.91%-11.46%-13.53%3.7%4.95%-1.69%-1.26%0.4%-41.61%-1.99%-3.04%-0.39%6.51%
Income Tax2.18M5.66M-23.36M16.1M12.87M5.42M3.67M3.62M6.16M9.88M-2.08M-23K668K-1.8M4.57M7.35M-3.46M4.14M4.05M2.65M
Effective Tax Rate %2.71%10.25%447.16%31.14%34.33%-35.4%23.77%17.73%-8.15%-11.84%-9.04%-0.08%-7.09%23.47%209.63%-3.16%34.89%-25.37%-198.19%7.6%
Net Income62.5M35.08M2.37M22.42M12.2M-31.08M-156K5.99M-91.64M-98.65M9.68M11.92M-6.94M-4.33M-2.69M-120.81M-2.16M-6.38M-4.24M14.53M
Net Margin %8.65%4.31%0.3%3.09%1.75%-4.25%-0.02%0.85%-13.9%-15.99%1.56%1.99%-1.25%-0.71%-0.49%-21.6%-0.43%-1.19%-0.8%2.72%
Net Income Growth %412.48%212.85%1618.59%273.99%113.31%68.49%-101.61%-49.7%-1219.93%-2176.69%460.06%109.86%-222.03%32.05%36.54%-931.32%-132.15%-109.98%52.79%221.14%
Net Income (Continuing)78M49.57M18.13M35.61M24.62M-20.74M11.76M16.79M-81.68M-93.34M25.03M29.68M-10.09M-5.86M-2.39M-240.08M-6.46M-20.46M-6.09M32.18M
Discontinued Operations00000000000000000000
Minority Interest-558K76.76M-497K65.8M72.28M64.73M59.75M53.4M47.12M41.52M-139.48M-135.29M-132.22M-89.49M-80.81M-89.45M32.7M23.54M47.92M58.28M
EPS (Diluted)0.190.110.010.070.04-0.10-0.000.02-0.30-0.400.060.08-0.07-0.04-0.02-0.80-0.04-0.04-0.030.10
EPS Growth %405.32%210%-269.68%112.53%75%-100.83%-76.5%-351.81%-933.59%479.75%110%-54.06%9.37%44.37%-900%-207.75%-107.28%53.29%222.85%
EPS (Basic)0.190.110.010.070.04-0.10-0.000.02-0.30-0.400.060.08-0.07-0.04-0.02-0.80-0.04-0.04-0.030.10
Diluted Shares Outstanding328.93M324.81M324.75M322.36M323.96M309.85M309.65M318.96M307.28M243.71M159.69M154.89M152.11M151.48M151.39M150.99M149.89M149.37M149.29M151.99M
Basic Shares Outstanding328.93M313.37M314.17M313.74M311.05M309.85M309.65M309.12M305.48M243.71M161.37M153.74M152.11M151.48M151.39M150.99M149.89M149.37M149.29M149M
Dividend Payout Ratio--------------------